Cluster of differentiation 1d–invariant natural killer T-cell receptor ternary complex (CD1d-iNKT TCR complex)

The Cluster of differentiation 1d–invariant natural killer T-cell receptor (CD1d-iNKT TCR) ternary complex is a specialized immunological assembly that mediates the activation of invariant Natural Killer T (iNKT) cells [2, 7]. This complex is composed of the non-classical MHC class I-like molecule CD1d, a lipid or glycolipid antigen, and the semi-invariant T-cell receptor (TCR) of iNKT cells, which in humans typically consists of the Vα24-Jα18 and Vβ11 chains [1, 4]. Upon formation of the ternary complex, iNKT cells are rapidly activated to produce a wide range of cytokines, such as interferon-gamma and interleukin-4, effectively bridging the innate and adaptive immune systems [3, 6]. This interaction plays a vital role in antitumor immunity, defense against microbial pathogens, and the regulation of inflammatory and autoimmune diseases [4, 8]. Therapeutic interventions target this complex using synthetic glycolipid agonists like alpha-galactosylceramide to modulate immune responses, although challenges such as iNKT cell anergy and excessive cytokine release must be carefully managed [1, 10].

Other names

CD1d-restricted invariant NKT TCR complexiNKT TCR-antigen-CD1d complexType I NKT TCR-CD1d complexCD1d-glycolipid-iNKT TCR complexVα24-Jα18 TCR-CD1d complex

The mechanism of action involves the binding of glycolipid agonists to the hydrophobic pockets of the CD1d molecule on antigen-presenting cells, which then forms a ternary complex with the invariant T-cell receptor (TCR) of iNKT cells; this interaction triggers a rapid signaling cascade leading to the secretion of diverse cytokines and the activation of both innate and adaptive immune components [1, 2, 7].